Further promising data seen with Biogen Alzheimer's drug: study – Reuters
|
Further promising data seen with Biogen Alzheimer’s drug: study
Reuters Gradually increasing the dose of Biogen Inc’s experimental Alzheimer’s disease drug appeared to cause less risk of brain swelling than higher fixed doses, according to interim 12-month results from a small study released on Thursday. The closely … |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.